You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Abbott Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?

ABBOTT has one hundred and eleven approved drugs.



Summary for Abbott
US Patents:0
Tradenames:89
Ingredients:62
NDAs:111

Drugs and US Patents for Abbott

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 018954-001 Jul 9, 1985 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Abbott AMINOSYN 3.5% IN PLASTIC CONTAINER amino acids INJECTABLE;INJECTION 018875-001 Aug 8, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Abbott GENTAMICIN SULFATE gentamicin sulfate INJECTABLE;INJECTION 062413-001 Aug 11, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Abbott A-METHAPRED methylprednisolone sodium succinate INJECTABLE;INJECTION 089575-001 Feb 22, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Abbott LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 089362-001 May 25, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Abbott ERYTHROCIN erythromycin lactobionate INJECTABLE;INJECTION 062586-002 Jan 4, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Abbott

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-004 Aug 7, 1987 5,212,176 ⤷  Try a Trial
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-004 Dec 14, 1994 4,251,532 ⤷  Try a Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-001 Nov 22, 1997 5,436,272*PED ⤷  Try a Trial
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-004 Aug 7, 1987 5,412,095 ⤷  Try a Trial
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987 4,112,097 ⤷  Try a Trial
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-001 Aug 7, 1987 4,251,532 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ABBOTT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 10 mg and 15 mg ➤ Subscribe 2009-08-14
➤ Subscribe Capsules 100 mg ➤ Subscribe 2012-10-31
➤ Subscribe Tablets 100 mg ➤ Subscribe 2010-12-21
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.